API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

1,6-Hexanediol Diglycidyl Ether: Properties and Applications as Cross-linker

1,6-Hexanediol diglycidyl ether is a vital compound for enhancing mechanical strength and biocompatibility in industrial applications through its crosslinking capabilities and unique properties.

Apr 9,2024  API

Calcium Folinate 10 mg/ml Injection and Calcium Folinate Tablets

Folinic acid (calcium folinate or leucovorin) is not a chemotherapy drug. It is a metabolically active, reduced form of folic acid rapidly absorbed and extensively metabolized in the liver to other fo

Apr 8,2024  API

Zinc complexes of 6-methyl-2-pyridinecarboxylic acid. Crystal structure of [Zn(MeC5H3NCOO)2(H2O)] · H2O

Reaction of Zn(AcO)2 · 2H2O with 6-methyl-2-pyridinecarboxylic acid (L) yielded a new compound [Zn(MeC5H3NCOO)2(H2O)] · H2O.

Apr 8,2024  API

Q:Physicochemical properties of 3-Iodophenol and its derivatives

A:3-Iodophenol is a halogenated phenolic compound used as a reagent in esterification, electrophilic aromatic substitution, alkylation, nucleophilic aromatic substitution, Mitsunobu, transition metal-ca

Apr 8,2024  API

Ethyl-2,2-dimethyl-7-bromoheptanoate: Applications as Pharmaceutical Intermediate and Preparation Method

Ethyl-2,2-dimethyl-7-bromoheptanoate is crucial for bempedoic acid synthesis, ensuring high efficiency and purity, advancing pharmaceutical synthesis methodologies.

Apr 8,2024  API

Ginsenoside Rg3: Potential and Molecular Mechanisms of in Cancer Treatment

Ginsenoside Rg3 exhibits potent anti-cancer effects by inducing apoptosis, inhibiting proliferation, and demonstrating significant anti-angiogenic properties.

Apr 8,2024  API

Josamycin: Pharmacodynamics, Pharmacokinetics and Indications

Josamycin, a macrolide antibiotic, inhibits bacterial protein synthesis and is effective against various infections due to its unique pharmacokinetic profile.

Apr 8,2024  API

The Role of Dolutegravir Sodium in Transforming HIV Care: From Mechanism of Action to Clinical Application

Dolutegravir sodium is a potent antiretroviral medication primarily used in the treatment of human immunodeficiency virus (HIV) infection.

Apr 8,2024  API

Beryllium Diboride: Crystal Structure

It was shown that Beryllium Diboride has four stable crystal structures, cubic (space group , NO.216), orthorhombic (space group Pnma, NO.62), orthorhombic (space group Pbam, NO.55 ) and hexagonal (sp

Apr 3,2024  API

Dabrafenib Mesylate(GSK-2118436B): Pharmacodynamics and Applications in Cancer

Dabrafenib Mesylate(GSK-2118436B) targets BRAF V600E in cancer, synergizing with trametinib to inhibit the RAS/RAF/MEK/ERK pathway, showing efficacy in various cancers.

Apr 3,2024  API
Prev12345678910...Next>  Go to Page